Legend Biotech (LEGN) Change in Accured Expenses (2020 - 2025)

Legend Biotech's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $6.8 million for Q3 2025.

• Quarterly Change in Accured Expenses rose 552.75% year-over-year to $6.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$12.5 million (down 116.72% YoY) and the FY2024 annual result came in at $45.7 million, up 3587.94% from the prior year.
• Change in Accured Expenses was $6.8 million for Q3 2025 at Legend Biotech, down from $20.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $77.0 million in Q4 2021 and bottomed at -$39.2 million in Q1 2023.
• A 5-year average of $15.4 million and a median of $7.4 million in 2024 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses jumped 1476.25% — and 2025, when it sank 623.51%.
• Legend Biotech's Change in Accured Expenses stood at $77.0 million in 2021, then tumbled by 97.73% to $1.7 million in 2022, then soared by 1476.25% to $27.5 million in 2023, then slumped by 105.36% to -$1.5 million in 2024, then jumped by 558.97% to $6.8 million in 2025.
• Business Quant data shows LEGN's Change in Accured Expenses at $6.8 million in Q3 2025, $20.9 million in Q2 2025, and -$38.6 million in Q1 2025.